BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20037162)

  • 1. LXR-SREBP-1c-phospholipid transfer protein axis controls very low density lipoprotein (VLDL) particle size.
    Okazaki H; Goldstein JL; Brown MS; Liang G
    J Biol Chem; 2010 Feb; 285(9):6801-10. PubMed ID: 20037162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles.
    Grefhorst A; Elzinga BM; Voshol PJ; Plösch T; Kok T; Bloks VW; van der Sluijs FH; Havekes LM; Romijn JA; Verkade HJ; Kuipers F
    J Biol Chem; 2002 Sep; 277(37):34182-90. PubMed ID: 12097330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical Role of SREBP-1c Large-VLDL Pathway in Environment-Induced Hypertriglyceridemia of Apo AV Deficiency.
    Takanashi M; Kimura T; Li C; Tanaka M; Matsuhashi A; Yoshida H; Noda A; Xu P; Takase S; Okazaki S; Iizuka Y; Kumagai H; Ikeda Y; Gotoda T; Takahashi M; Yagyu H; Ishibashi S; Yamauchi T; Kadowaki T; Liang G; Okazaki H
    Arterioscler Thromb Vasc Biol; 2019 Mar; 39(3):373-386. PubMed ID: 30700132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid hormone-responsive SPOT 14 homolog promotes hepatic lipogenesis, and its expression is regulated by liver X receptor α through a sterol regulatory element-binding protein 1c-dependent mechanism in mice.
    Wu J; Wang C; Li S; Li S; Wang W; Li J; Chi Y; Yang H; Kong X; Zhou Y; Dong C; Wang F; Xu G; Yang J; Gustafsson JÅ; Guan Y
    Hepatology; 2013 Aug; 58(2):617-28. PubMed ID: 23348573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c.
    Liang G; Yang J; Horton JD; Hammer RE; Goldstein JL; Brown MS
    J Biol Chem; 2002 Mar; 277(11):9520-8. PubMed ID: 11782483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR.
    Cha JY; Repa JJ
    J Biol Chem; 2007 Jan; 282(1):743-51. PubMed ID: 17107947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coadministration of a liver X receptor agonist and a peroxisome proliferator activator receptor-alpha agonist in Mice: effects of nuclear receptor interplay on high-density lipoprotein and triglyceride metabolism in vivo.
    Beyer TP; Schmidt RJ; Foxworthy P; Zhang Y; Dai J; Bensch WR; Kauffman RF; Gao H; Ryan TP; Jiang XC; Karathanasis SK; Eacho PI; Cao G
    J Pharmacol Exp Ther; 2004 Jun; 309(3):861-8. PubMed ID: 14960661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cilostazol inhibits insulin-stimulated expression of sterol regulatory binding protein-1c via inhibition of LXR and Sp1.
    Jung YA; Kim HK; Bae KH; Seo HY; Kim HS; Jang BK; Jung GS; Lee IK; Kim MK; Park KG
    Exp Mol Med; 2014 Jan; 46(1):e73. PubMed ID: 24458133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phospholipid transfer protein is regulated by liver X receptors in vivo.
    Cao G; Beyer TP; Yang XP; Schmidt RJ; Zhang Y; Bensch WR; Kauffman RF; Gao H; Ryan TP; Liang Y; Eacho PI; Jiang XC
    J Biol Chem; 2002 Oct; 277(42):39561-5. PubMed ID: 12177004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of bile acid, cholesterol, and fatty acid synthesis in chicken primary hepatocytes by different concentrations of T0901317, an agonist of liver X receptors.
    Sato K; Kamada T
    Comp Biochem Physiol A Mol Integr Physiol; 2011 Feb; 158(2):201-6. PubMed ID: 21056113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of AMPK suppression of LXR-dependent Srebp-1c transcription.
    Yap F; Craddock L; Yang J
    Int J Biol Sci; 2011; 7(5):645-50. PubMed ID: 21647332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertriglyceridemia in lecithin-cholesterol acyltransferase-deficient mice is associated with hepatic overproduction of triglycerides, increased lipogenesis, and improved glucose tolerance.
    Ng DS; Xie C; Maguire GF; Zhu X; Ugwu F; Lam E; Connelly PW
    J Biol Chem; 2004 Feb; 279(9):7636-42. PubMed ID: 14668345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LXRalpha activation perturbs hepatic insulin signaling and stimulates production of apolipoprotein B-containing lipoproteins.
    Basciano H; Miller A; Baker C; Naples M; Adeli K
    Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G323-32. PubMed ID: 19497957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. I. PPARs suppress sterol regulatory element binding protein-1c promoter through inhibition of LXR signaling.
    Yoshikawa T; Ide T; Shimano H; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Yatoh S; Kitamine T; Okazaki H; Tamura Y; Sekiya M; Takahashi A; Hasty AH; Sato R; Sone H; Osuga J; Ishibashi S; Yamada N
    Mol Endocrinol; 2003 Jul; 17(7):1240-54. PubMed ID: 12730331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ursodeoxycholic acid inhibits liver X receptor α-mediated hepatic lipogenesis via induction of the nuclear corepressor SMILE.
    Lee JM; Gang GT; Kim DK; Kim YD; Koo SH; Lee CH; Choi HS
    J Biol Chem; 2014 Jan; 289(2):1079-91. PubMed ID: 24265317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiatherosclerotic effects of a novel synthetic tissue-selective steroidal liver X receptor agonist in low-density lipoprotein receptor-deficient mice.
    Peng D; Hiipakka RA; Dai Q; Guo J; Reardon CA; Getz GS; Liao S
    J Pharmacol Exp Ther; 2008 Nov; 327(2):332-42. PubMed ID: 18723776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stearoyl-coenzyme A desaturase 1 deficiency protects against hypertriglyceridemia and increases plasma high-density lipoprotein cholesterol induced by liver X receptor activation.
    Chu K; Miyazaki M; Man WC; Ntambi JM
    Mol Cell Biol; 2006 Sep; 26(18):6786-98. PubMed ID: 16943421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The liver X receptor ligand T0901317 down-regulates APOA5 gene expression through activation of SREBP-1c.
    Jakel H; Nowak M; Moitrot E; Dehondt H; Hum DW; Pennacchio LA; Fruchart-Najib J; Fruchart JC
    J Biol Chem; 2004 Oct; 279(44):45462-9. PubMed ID: 15317819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sterol regulatory element-binding protein-1 determines plasma remnant lipoproteins and accelerates atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Karasawa T; Takahashi A; Saito R; Sekiya M; Igarashi M; Iwasaki H; Miyahara S; Koyasu S; Nakagawa Y; Ishii K; Matsuzaka T; Kobayashi K; Yahagi N; Takekoshi K; Sone H; Yatoh S; Suzuki H; Yamada N; Shimano H
    Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1788-95. PubMed ID: 21546605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiopoietin-like protein 3 mediates hypertriglyceridemia induced by the liver X receptor.
    Inaba T; Matsuda M; Shimamura M; Takei N; Terasaka N; Ando Y; Yasumo H; Koishi R; Makishima M; Shimomura I
    J Biol Chem; 2003 Jun; 278(24):21344-51. PubMed ID: 12672813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.